In the latest move in a discovery dispute that threatens to throw New York’s multidefendant opioid trial off the rails, Suffolk County Supreme Court Justice Jerry Garguilo revised the order to show cause to include a second law firm that has represented the drug company Endo Pharmaceuticals.

Redgrave LLP, an 11-year-old firm headquartered in the Washington, D.C., area, has now been ordered to appear alongside Endo and Arnold & Porter Kaye Scholer to explain why they should not be held in civil contempt, among other potential sanctions, according to the order. The hearing has been scheduled for Wednesday.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]